International Patent: TREATMENT OF TARDIVE DYSKINESIA BY MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88

GENEVA, Nov. 6 -- ACADIA PHARMACEUTICALS INC. filed a patent application (US2026/026209) for “TREATMENT OF TARDIVE DYSKINESIA BY MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88”. With publication no. WO/2026/232027, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/16

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....